Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases

L Paz-Ares, R Dziadziuszko, A Drilon, T John, M Krebs, G Demetri, A Shaw, S Siena, J Wolf, A Farago, B Simmons, C Ye, X Huang, R Doebele